Difference between revisions of "Xu Ruoyan"
From Bioblast
| Line 12: | Line 12: | ||
|city=London | |city=London | ||
|country=United Kingdom | |country=United Kingdom | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Revision as of 15:58, 27 June 2014
| Name | Xu Ruoyan, |
|---|---|
| Institution | Centre for Molecular Oncology
Barts Cancer Institute - a Cancer Research UK Centre of Excellence Queen Mary, University of London John Vane Science Centre |
| Address | Charterhouse Square, EC1M 6BQ |
| City | London |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | UK London Bianchi K |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Li 2014 Mol Cell Biol | 2014 | Li S, Yao Y, Xu R, Pesenti S, Cottet-Rousselle C, Rieusset J, Tokarska-Schlattner M, Liao K, Schlattner U, Rousseau D (2014) ATAD3 is a limiting factor in mitochondrial biogenesis and adipogenesis of white adipocyte-like 3T3-L1 cells. Mol Cell Biol 37. |
Abstracts
| Published | Reference | |
|---|---|---|
| Xu 2014 Abstract IOC96 | 2014 | Xu R (2014) Exploring the role of IKKΞ΅ in cancer metabolism. Mitochondr Physiol Network 19.11. |
